Valuation: SMAIO

Market Cap 4.83Cr 5.53Cr 4.47Cr 4.13Cr 7.77Cr 531.18Cr 7.91Cr 53Cr 21Cr 260.1Cr 21Cr 20Cr 895.6Cr P/E 2026 *
-24.9x
P/E 2027 * 123x
Enterprise Value 4.62Cr 5.29Cr 4.27Cr 3.95Cr 7.43Cr 508.1Cr 7.57Cr 51Cr 20Cr 248.8Cr 20Cr 19Cr 856.68Cr EV / Sales 2026 *
3.85x
EV / Sales 2027 * 2.8x
Free-Float
29.17%
Yield 2026 *
-
Yield 2027 * -
1 week-1.15%
Current month+10.57%
1 month+9.16%
3 months+17.86%
6 months+30.99%
Current year+37.28%
1 week 8.3
Extreme 8.3
8.94
1 month 7.44
Extreme 7.44
8.94
Current year 6
Extreme 6
9.1
1 year 5.5
Extreme 5.5
9.1
3 years 2.14
Extreme 2.14
9.1
5 years 1.9
Extreme 1.9
9.1
10 years 1.9
Extreme 1.9
9.1
Manager TitleAgeSince
Chief Executive Officer - 29/12/2008
Director of Finance/CFO - 01/06/2022
Chief Tech/Sci/R&D Officer - 01/07/2020
Director TitleAgeSince
Chairman - 30/07/2021
Change 5-day change 1-year change 3-year change Capi.($)
0.00%-1.15%+47.93%+245.97% 5.51Cr
-2.48%-6.72%+44.19%+156.43% 1,05400Cr
-1.52%-5.01%+61.87%+58.79% 62TCr
-1.30%-3.88%+27.81%+79.97% 44TCr
-1.12%-1.45%+27.34%+22.20% 32TCr
-1.73%-2.14%+27.22%+44.70% 28TCr
-1.95%-12.31%+18.32%+19.69% 26TCr
-1.45%-0.44%-27.17%-38.86% 22TCr
-1.44%-3.49%+19.60%+56.20% 19TCr
-1.04%-4.63%+16.01%+68.47% 16TCr
Average -1.39%-1.65%+26.31%+71.36% 35.56TCr
Weighted average by Cap. -1.51%-1.69%+33.44%+77.30%

Financials

2026 *2027 *
Net sales 1.2Cr 1.37Cr 1.11Cr 1.02Cr 1.93Cr 131.82Cr 1.96Cr 13Cr 5.19Cr 65Cr 5.15Cr 5.04Cr 222.25Cr 1.68Cr 1.92Cr 1.55Cr 1.43Cr 2.7Cr 184.19Cr 2.74Cr 18Cr 7.25Cr 90Cr 7.2Cr 7.04Cr 310.56Cr
Net income -16.74L -19.15L -15.47L -14.29L -26.92L -18Cr -27.4L -1.84Cr -72.38L -9.01Cr -71.93L -70.34L -31Cr 3L 3L 3L 2L 4L 3.06Cr 5L 30.65L 12.02L 1.5Cr 11.95L 11.68L 5.15Cr
Net Debt -21L -24.03L -19.41L -17.94L -33.78L -23Cr -34.39L -2.32Cr -90.83L -11Cr -90.26L -88.27L -39Cr -14L -16.02L -12.94L -11.96L -22.52L -15Cr -22.92L -1.54Cr -60.55L -7.53Cr -60.17L -58.85L -26Cr
Logo SMAIO
S.M.A.I.O « Software, Machines and Adaptive Implants in Orthopaedics » is specialized in the design, manufacture and marketing of implantable medical devices for the treatment of spinal pathologies. The company offers the Kheiron Spinal Fixation System, a device that incorporates many implants, intended for the immobilization and stabilization of spinal segments as an adjunct to fusion of the thoracic, lumbar and/or sacral spine. In addition, S.M.A.I.O has developed the Keops and Balance Analyzer 3D surgical planning and patient database management software, and the company also offers training programs. Net sales break down by source of revenue between sales of products (98.9%) and services (1.1%). Net sales are distributed geographically as follows: France (9.8%), Europe (12.2%), the United States (76.2%), Oceania (1%), Middle East and Africa (0.7%) and Canada (0.1%).
Employees
45
Date Price Change Volume
14/26/14 8.580 0.00% 662
13/26/13 €8.580 +0.94% 106
10/26/10 €8.500 -0.93% 1,388
09/26/09 €8.580 -0.23% 141
08/26/08 €8.600 -1.15% 2,504
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
8.580EUR
Average target price
8.250EUR
Spread / Average Target
-3.85%

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ALSMA Stock